long-term effects of glp-1 medications Medications: Everything You Need to Know The GLP-1 Agonists and Obesity:

In hepatocyte cultures, retatrutide produces a complex pattern reflecting the competing effects of glucagon receptor activation (raising glucose output and lipid oxidation) and GLP-1 signalling (lowering glucose output and lipogenesis)

[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Miyamoto J., Igarashi M., Watanabe K., Karaki S.I., Mukouyama H., Kishino S., Li X., Ichimura A., Irie J., Sugimoto Y., et al

Understanding how long peptides take to work across different categories provides a realistic framework for setting expectations during the escalation phase

Potential to Treat Liver Diseases (NAFLD/NASH): Retatrutide is also being investigated for its potential benefits in treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are associated with metabolic disorders